A perioperative study of safusidenib in patients with IDH1 mutated glioma

被引:0
|
作者
Whittle, J. R. [1 ]
Rosenthal, M. [1 ]
Spiteri, M. [2 ]
Cain, S. [3 ]
Topp, M. D. [1 ]
Shaya, S. [1 ]
Jones, J. [3 ]
Valkovic, A. [2 ]
Fatunla, O. [2 ]
Dimou, J.
Tobler, R. [2 ]
Roberts-Thomson, S. [4 ]
McArdle, D. [5 ]
Lui, E. [5 ]
Nijagal, B. [6 ]
Grimmond, S. M. [7 ]
Best, S. A. [2 ]
Freytag, S. [2 ]
Drummond, K. [3 ]
机构
[1] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
[2] WEHI Walter & Eliza Hall Inst Med Res, Personalised Oncol, Parkville, Vic, Australia
[3] Royal Melbourne Hosp, Neurosurg, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Anat Pathol, Melbourne, Vic, Australia
[5] Royal Melbourne Hosp, Radiol, Melbourne, Vic, Australia
[6] Bio21, Metabolom, Melbourne, Vic, Australia
[7] Univ Melbourne, Ctr Canc Res, Ctr Canc Res UMCCR, Victorian Comprehens Canc Ctr, Parkville, Vic, Australia
关键词
D O I
10.1016/j.annonc.2024.08.513
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
443O
引用
收藏
页码:S407 / S407
页数:1
相关论文
共 50 条
  • [21] Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma
    Sun, Chao
    Xiao, Liming
    Zhao, Yuanlin
    Shi, Jiankuan
    Yuan, Yuan
    Gu, Yu
    Zhang, Feng
    Gao, Xing
    Yang, Ying
    Yang, Risheng
    Qin, Junhui
    Zhang, Jin
    Wang, Chao
    Wang, Yingmei
    Wang, Zhe
    Hu, Peizhen
    Chang, Ting
    Wang, Liang
    Wang, Gang
    Chen, Huangtao
    Li, Zhuyi
    Ye, Jing
    TRANSLATIONAL ONCOLOGY, 2020, 13 (04):
  • [22] IDH1 Mutation as a Predictor of Glioma Progression.
    Knobbe, C.
    Nesrin, S.
    von Deimling, A.
    Mak, T. W.
    Guha, A.
    Croul, S. E.
    MODERN PATHOLOGY, 2011, 24 : 382A - 382A
  • [23] Immunostaining for IDH1 mutation detection in diffuse glioma
    Cartlidge, C.
    Ismail, A.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2022, 48
  • [24] THE KETOGENIC DIET IS INEFFECTIVE IN PRECLINICAL MODELS OF IDH1 WILD-TYPE AND IDH1 MUTANT GLIOMA
    Javier, Rodrigo
    Horbinski, Craig
    NEURO-ONCOLOGY, 2021, 23 : 208 - 208
  • [25] In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma
    Khurshed, Mohammed
    Molenaar, Remco J.
    Lenting, Krissie
    Leenders, William P.
    van Noorden, Cornelis J. F.
    ONCOTARGET, 2017, 8 (30) : 49165 - 49177
  • [26] The Ketogenic Diet is Ineffective in Preclinical Models of IDH1 Wild-type and IDH1 Mutant Glioma
    Horbinski, Craig
    Javier, Rodrigo
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 563 - 563
  • [27] Mutant IDH1 Promotes Glioma Formation In Vivo
    Philip, Beatrice
    Yu, Diana X.
    Silvis, Mark R.
    Shin, Clifford H.
    Robinson, James P.
    Robinson, Gemma L.
    Welker, Adam E.
    Angel, Stephanie N.
    Tripp, Sheryl R.
    Sonnen, Joshua A.
    VanBrocklin, Matthew W.
    Gibbons, Richard J.
    Looper, Ryan E.
    Colman, Howard
    Holmen, Sheri L.
    CELL REPORTS, 2018, 23 (05): : 1553 - 1564
  • [28] Metabolic Reprogramming in Mutant IDH1 Glioma Cells
    Izquierdo-Garcia, Jose L.
    Viswanath, Pavithra
    Eriksson, Pia
    Chaumeil, Myriam M.
    Pieper, Russell O.
    Phillips, Joanna J.
    Ronen, Sabrina M.
    PLOS ONE, 2015, 10 (02):
  • [29] Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma
    Rimini, Margherita
    Fabregat-Franco, Carles
    Burgio, Valentina
    Lonardi, Sara
    Niger, Monica
    Scartozzi, Mario
    Rapposelli, Ilario Giovanni
    Aprile, Giuseppe
    Ratti, Francesca
    Pedica, Federica
    Verdaguer, Helena
    Rizzato, Mario
    Nichetti, Federico
    Lai, Eleonora
    Cappetta, Alessandro
    Macarulla, Teresa
    Fassan, Matteo
    De Braud, Filippo
    Pretta, Andrea
    Simionato, Francesca
    De Cobelli, Francesco
    Aldrighetti, Luca
    Fornaro, Lorenzo
    Cascinu, Stefano
    Casadei-Gardini, Andrea
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [30] MUTANT IDH1 PROMOTES GLIOMA FORMATION IN VIVO
    Yu, Diana
    Boekholder, Ryan
    VanBrocklin, Matthew
    Sonnen, Joshua
    Colman, Howard
    Holmen, Sheri
    NEURO-ONCOLOGY, 2018, 20 : 272 - 272